Contraindications of Azithromycin
Azithromycin is absolutely contraindicated in patients with hypersensitivity to azithromycin, erythromycin, any macrolide, or any ketolide antibiotic, and in those with a history of cholestatic jaundice or hepatic dysfunction associated with previous azithromycin use. 1
Absolute Contraindications
Based on FDA labeling and clinical guidelines, the following are absolute contraindications:
- Known hypersensitivity reactions to azithromycin, erythromycin, any macrolide antibiotic, or ketolide antibiotics 1, 2, 1, 3
- History of cholestatic jaundice or hepatic dysfunction specifically associated with prior azithromycin use 1
High-Risk Situations Requiring Extreme Caution or Avoidance
Cardiac Risk Factors
Azithromycin should be avoided or used only with extreme caution in patients with cardiac risk factors for QT prolongation, as it can cause fatal cardiac arrhythmias including torsades de pointes. 3 Specific high-risk groups include:
- Known prolonged QT interval
- History of torsades de pointes
- Congenital long QT syndrome
- Bradyarrhythmias or uncompensated heart failure
- Concurrent use of Class IA antiarrhythmics (quinidine, procainamide) or Class III antiarrhythmics (dofetilide, amiodarone, sotalol)
- Uncorrected hypokalemia or hypomagnesemia
- Clinically significant bradycardia
- Elderly patients (more susceptible to QT interval effects) 3
Active or Suspected Non-Tuberculous Mycobacterial (NTM) Infection
Current NTM infection is an absolute contraindication to low-dose macrolide monotherapy due to the high risk of developing macrolide resistance, which severely compromises future treatment success. 4 Patients with any clinical suspicion of NTM disease must be screened via sputum examination before initiating azithromycin. If positive for pathogenic NTM species, azithromycin monotherapy is contraindicated. 4
Severe Hepatic Impairment
Azithromycin should be prescribed with extreme caution in patients with impaired hepatic function, as abnormal liver function, hepatitis, cholestatic jaundice, hepatic necrosis, and hepatic failure (some fatal) have been reported. 2, 3 Discontinue immediately if signs or symptoms of hepatitis occur. 3
Special Population Considerations
Infants <1 Month of Age
While not an absolute contraindication, azithromycin use in neonates requires careful consideration. For pertussis treatment specifically, azithromycin is actually the preferred macrolide over erythromycin in infants <1 month due to lower risk of infantile hypertrophic pyloric stenosis (IHPS). 2 However, infants receiving any macrolide at this age should be monitored for IHPS and other serious adverse events. 2
Patients at Risk of Bacteremia
Azithromycin should be avoided in patients with significant risk of bacteremia, including those with:
- Moderate to severe pneumonia
- Cystic fibrosis
- Nosocomially acquired infections
- Known or suspected bacteremia
- Need for hospitalization
- Elderly or debilitated status
- Immunodeficiency or functional asplenia 3, 5
Important Drug Interactions
While not absolute contraindications, monitor closely when azithromycin is used with:
- Drugs metabolized by cytochrome P450 system (digoxin, triazolam, ergot alkaloids) 2
- Aluminum- or magnesium-containing antacids (reduces azithromycin absorption—separate administration) 2
Common Pitfalls to Avoid
Do not assume azithromycin is safe in all cardiac patients—actively screen for QT prolongation risk factors and obtain baseline ECG in high-risk patients 3
Do not initiate azithromycin without screening for NTM in patients with chronic respiratory disease and clinical suspicion of mycobacterial infection 4
Do not continue azithromycin if hepatitis develops—discontinue immediately as hepatic failure can be fatal 3
Do not use azithromycin for severe pneumonia requiring hospitalization or in immunocompromised patients without careful risk-benefit assessment 3, 5